TNDM
HEALTHCARETandem Diabetes Care Inc
$18.03-1.39 (-7.16%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TNDM Today?
No stock-specific AI insight has been generated for TNDM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$9.98$29.65
$18.03
Fundamentals
Market Cap$1.3B
P/E Ratio—
EPS$-3.04
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume3.1M
Avg Volume (10D)—
Shares Outstanding68.5M
TNDM News
22 articles- Tandem Diabetes Care Q1 Earnings Call HighlightsMarketbeat·May 9, 2026
- Company News for May 8, 2026Yahoo Finance·May 8, 2026
- Tandem to file tubeless insulin pump with FDA this quarterMedtechdive·May 8, 2026
- Tandem Diabetes Care Announces First Quarter 2026 Financial ResultsBioSpace·May 8, 2026
- Tandem Diabetes Care, Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- Tandem (TNDM) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key MetricsYahoo Finance·May 7, 2026
- Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%Yahoo Finance·May 7, 2026
- 3 Russell 2000 Stocks We Approach with CautionYahoo Finance·May 5, 2026
- How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Control-IQ+ Use To Type 1 PregnanciesYahoo Finance·May 3, 2026
- TD Cowen Raises Tandem Diabetes (TNDM) Price Target, Keeps Buy RatingYahoo Finance·Apr 30, 2026
- Tandem Diabetes Care Announces Upcoming Conference PresentationsYahoo Finance·Apr 29, 2026
- Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 DiabetesYahoo Finance·Apr 27, 2026
- FDA Flags High-Risk Recall For Tandem Diabetes Mobi PumpsBenzinga·Apr 24, 2026
- Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)Yahoo Finance·Apr 23, 2026
- Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and YpsomedYahoo Finance·Apr 21, 2026
- 3 Stocks Under $50 Walking a Fine LineYahoo Finance·Apr 7, 2026
- Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price WeaknessYahoo Finance·Apr 4, 2026
- Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 2, 2026
- Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To KnowYahoo Finance·Mar 27, 2026
- Tandem Diabetes Care, Inc. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Mar 27, 2026
All 22 articles loaded
Price Data
Open$19.48
Previous Close$19.42
Day High$19.49
Day Low$17.93
52 Week High$29.65
52 Week Low$9.98
52-Week Range
$9.98$29.65
$18.03
Fundamentals
Market Cap$1.3B
P/E Ratio—
EPS$-3.04
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume3.1M
Avg Volume (10D)—
Shares Outstanding68.5M
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—